PURPOSE: To evaluate the effects of total body irradiation (TBI) on the endocrine system in adults treated with hematopoietic cell transplantation (HCT) during childhood. METHODS: We studied 40 patients who underwent HCT between 1988 and 2004, mainly for childhood cancer. In 23 patients, the conditioning regimen consisted of high-dose chemotherapy and TBI (TBI+). In the other 17 patients, who did not receive TBI (TBI-), HCT was performed after high-dose chemotherapy alone. RESULTS: Overall, 34% of patients in the TBI+ group showed growth hormone deficiency, compared with none of the patients in the TBI- group (P < 0.05). Leydig cell failure was found in 23% of patients in the TBI+ group and in 0% of the patients in the TBI- group. Elevated FSH levels, suggesting spermatogenesis damage, were found in all the patients receiving TBI and in 36% of the patients in the TBI- group (P < 0.001). Also, primary hypothyroidism was more common in TBI+ (34%) than in TBI- (5.8%) patients (P < 0.05). CONCLUSIONS: Our data indicate that endocrine late effects after HCT are more frequent in patients who received TBI, an observation that should be considered, even if the choice of the conditioning regimen is determined by the underlying condition in most cases.
PURPOSE: To evaluate the effects of total body irradiation (TBI) on the endocrine system in adults treated with hematopoietic cell transplantation (HCT) during childhood. METHODS: We studied 40 patients who underwent HCT between 1988 and 2004, mainly for childhood cancer. In 23 patients, the conditioning regimen consisted of high-dose chemotherapy and TBI (TBI+). In the other 17 patients, who did not receive TBI (TBI-), HCT was performed after high-dose chemotherapy alone. RESULTS: Overall, 34% of patients in the TBI+ group showed growth hormone deficiency, compared with none of the patients in the TBI- group (P < 0.05). Leydig cell failure was found in 23% of patients in the TBI+ group and in 0% of the patients in the TBI- group. Elevated FSH levels, suggesting spermatogenesis damage, were found in all the patients receiving TBI and in 36% of the patients in the TBI- group (P < 0.001). Also, primary hypothyroidism was more common in TBI+ (34%) than in TBI- (5.8%) patients (P < 0.05). CONCLUSIONS: Our data indicate that endocrine late effects after HCT are more frequent in patients who received TBI, an observation that should be considered, even if the choice of the conditioning regimen is determined by the underlying condition in most cases.
Authors: A Cohen; A Rovelli; M T van Lint; F Merlo; A Gaiero; R Mulas; A Balduzzi; P Corti; C Uderzo; A Bacigalupo Journal: Bone Marrow Transplant Date: 2001-12 Impact factor: 5.483
Authors: Joanna L Perkins; Alicia S Kunin-Batson; Nancy M Youngren; Kirsten K Ness; Kami J Ulrich; Melissa J Hansen; Anna Petryk; Julia Steinberger; Fiona S Anderson; K Scott Baker Journal: Pediatr Blood Cancer Date: 2007-12 Impact factor: 3.167
Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun Journal: CA Cancer J Clin Date: 2006 Mar-Apr Impact factor: 508.702
Authors: E Brignardello; F Felicetti; A Castiglione; N Fortunati; P Matarazzo; E Biasin; C Sacerdote; U Ricardi; F Fagioli; A Corrias; E Arvat Journal: J Endocrinol Invest Date: 2014-10-25 Impact factor: 4.256
Authors: E Brignardello; F Felicetti; A Castiglione; A Nervo; E Biasin; G Ciccone; F Fagioli; A Corrias Journal: J Cancer Res Clin Oncol Date: 2016-02-10 Impact factor: 4.553
Authors: Sogol Mostoufi-Moab; Elizabeth J Isaacoff; David Spiegel; Denise Gruccio; Jill P Ginsberg; Wendy Hobbie; Justine Shults; Mary B Leonard Journal: Pediatr Blood Cancer Date: 2013-07-02 Impact factor: 3.167
Authors: Susan R Rose; Vincent E Horne; Jonathan Howell; Sarah A Lawson; Meilan M Rutter; Gylynthia E Trotman; Sarah D Corathers Journal: Nat Rev Endocrinol Date: 2016-04-01 Impact factor: 43.330
Authors: Lisa M Madden; Alexander I Ngwube; Shalini Shenoy; Todd E Druley; Robert J Hayashi Journal: J Pediatr Hematol Oncol Date: 2015-03 Impact factor: 1.289